key: cord-0835190-b319ueow
authors: Lim, Kok Haw Jonathan; Murali, Krithika; Thorne, Eleanor; Punie, Kevin; Kamposioras, Konstantinos; Oing, Christoph; O’Connor, Miriam; Élez, Elena; Amaral, Teresa; Garrido, Pilar; Lambertini, Matteo; Devnani, Bharti; Westphalen, C. Benedikt; Morgan, Gilberto; Haanen, John B.A. G.; Hardy, Claire; Banerjee, Susana
title: The impact of COVID-19 on oncology professionals – one year on: lessons learned from the ESMO Resilience Task Force survey series
date: 2021-12-17
journal: ESMO Open
DOI: 10.1016/j.esmoop.2021.100374
sha: 501b7a8dbee9c54d1ca60d573b6adf88263e1602
doc_id: 835190
cord_uid: b319ueow

BACKGROUND: COVID-19 has had a significant impact on the well-being and job performance of oncology professionals globally. The ESMO Resilience Task Force collaboration set out to investigate and monitor well-being since COVID-19 in relation to work, lifestyle and support factors in oncology professionals one year on since the start of the pandemic. METHODS: An online, anonymous survey was conducted in February/March 2021 (Survey III). Key outcome variables included risk of poor well-being or distress (expanded Well-Being Index, eWBI), feeling burnout (single item from eWBI) and job performance since COVID-19. Longitudinal analysis of responses to the series of three surveys since COVID-19 was performed, and responses to job demands and resources questions were interrogated. SPSS V.26.0/V.27.0 and GraphPad Prism V9.0 were used for statistical analyses. RESULTS: Responses from 1269 participants from 104 countries were analysed in Survey III: 55% (n = 699/1269) female, 54% (n = 686/1269) >40 years, and 69% (n = 852/1230) of white ethnicity. There continues to be an increased risk of poor well-being or distress (n = 464/1169, 40%) and feeling burnout (n = 660/1169, 57%) compared Survey I (25% and 38% respectively, P < 0.0001), despite improved job performance. Compared to the initial period of the pandemic, more participants report feeling overwhelmed with workload (45% vs 29%, P < 0.0001). There remain concerns about the negative impact of the pandemic on career development/training (43%), job security (37%) and international fellowship opportunities (76%). Alarmingly, 25% (n = 266/1086) are considering changing their future career with 38% (n = 100/266) contemplating leaving the profession. CONCLUSION: Oncology professionals continue to face increased job demands. There is now significant concern regarding potential attrition in the oncology workforce. National and international stakeholders must act immediately and work closely with oncology professionals to draw up future-proof recovery plans.

@DrJonLim @kevinpunie @OingC1 @elena_elez @TeresaSAmaral @Piuchagarrido @matteolambe @devnani_bharti @BenWestphalen @weoncologists @OncoAlert 

Responses from 1269 participants from 104 countries were analysed in Survey III: 55% (n = 699/1269) female, 54% (n = 686/1269) >40 years, and 69% (n = 852/1230) of white ethnicity.

There continues to be an increased risk of poor well-being or distress (n = 464/1169, 40%) and feeling burnout (n = 660/1169, 57%) compared Survey I (25% and 38% respectively, P < 0.0001), despite improved job performance. Compared to the initial period of the pandemic, more participants report feeling overwhelmed with workload (45% vs 29%, P < 0.0001). There remain concerns about the negative impact of the pandemic on career development/training (43%), job security (37%) and international fellowship opportunities (76%). Alarmingly, 25%

J o u r n a l P r e -p r o o f (n = 266/1086) are considering changing their future career with 38% (n = 100/266) contemplating leaving the profession.

Oncology professionals continue to face increased job demands. There is now significant concern regarding potential attrition in the oncology workforce. National and international stakeholders must act immediately and work closely with oncology professionals to draw up future-proof recovery plans. [3] [4] [5] Additional temporising measures such as suspension of 'non-essential' palliative chemotherapy, cancer screening services, and favouring of less intensive treatment regimens have also impacted the nature of our work with potential for longer-term consequences. [6] [7] [8] [9] Since the COVID-19 pandemic, clinicians have been particularly challenged in their ability to provide cancer care to aspired standards with a concomitant diminution in meaningful professional activities. 4, 5 All of this whilst also contending with the risk to personal safety at work from COVID-19 infection and associated morbidity. 5 

Key outcome variables used throughout the survey series including risk of poor well-being or distress (expanded Well-Being Index, eWBI; score≥4, at risk) 10, 11 , feeling burnout (single item from eWBI) and job performance since COVID-19 (JP-CV; score≥3.5, favourable) have been previously described in detail. 4, 5 In Survey III, we also added relevant questions regarding 

A total of 1432 participants from 104 countries responded to the Survey III invitation. In the final analysis, we included data from all participants who consented and responded to key questions placed at the beginning of the survey on their perception of the current status of COVID-19 (trend, lockdown and vaccination) and provided basic demographic details including their country of work (n = 1269 (88.6%)). The majority (n = 1158/1269, 91.3%) completed the survey to the end. The personal and professional demographic characteristics of Survey III participants are outlined in Table 1 and Supplementary Table S1 Table S1 ).

As the COVID-19 pandemic continues, majority of participants have encountered some form of lockdown restrictions in their region of work ( (Table 2) .

More than a third of participants reported having regular asymptomatic testing for COVID-19

(n = 423/1082, 39.1%) ( Table 2) . A total of 160 participants (14.8%) have tested positive for COVID-19, of whom ten had required hospitalisation. Of those who had tested positive for COVID-19, around a third (n = 43/160, 26.9%) neither felt they had been given appropriate time to recover nor felt completely recovered upon their return to work (n = 60/160, 37.5%).

By February/March 2021, one in five participants disclosed that they have had a work colleague who died of COVID-19 (n = 215/1079, 19.9%).

Work routine has yet to return to pre-COVID-19 situation for over half of participants (n = 578/1269, 52.3%). In Survey III, around a fifth of participants (n = 238/1107, 21.5%) were either partially or fully redeployed. Participants continued to report several changes to their professional roles and duties as detailed in Supplementary Table S2 , with nearly half (n = 354/756, 46.8%) reporting an increase in overall hours of work. As expected, there remained an increased use of remote or virtual meetings and consultations (>80%). Of concern, over half of participants have reported a decrease in clinical trial activity (n = 392/648, 60.5%) and

general research activity (n = 366/664, 55.1%). About two-thirds of participants (n = 708/1108, 63.9%) were worried that COVID-19 would have a negative impact on the quality of cancer research at their institution.

Compared to Surveys I 4 and II 5 , there were now significantly more participants who were at risk of poor well-being or distress (n = 464/1169, 39.7%) and feeling burnout (n = 660/1169, 56.5%) (Chi-square test for trend, P < 0.0001) (Figure 1a (Figure 2 ).

We analysed responses to questions associated with job demands over the different timepoints studied in this survey series to identify reasons which may have potentially contributed to worsening distress and burnout ( Figure 3a ). Figure 3a) . Moreover, the majority of participants in Survey III reported that they J o u r n a l P r e -p r o o f had not been able to take time off for annual leave or holidays (n = 650/1084, 60.0%), and/or study leave (n = 863/1084, 79.6%) (Figure 3a ).

In addition, we also interrogated several domains in terms of personal and professional resources and coping strategies available to participants which could potentially alleviate job demands ( Figure 3b) . Here, the main areas of concern were regarding job security and participants' support systems (Figure 3b ). In particular, participants were concerned that the pandemic would have a negative impact on their personal job security (n = 386/1057, 36.5%).

Only over a third of participants (n = 346/1023, 33.8%) were not concerned that the COVID- Participants were questioned about their support systems, access to well-being support services, and the coping strategies they had been using to help themselves during the pandemic (details summarised in Figure 3b , and Supplementary Table S3 Table S3 ).

Finally, in Survey III, concerns with regards to attrition in the oncology workforce were Female and younger (≤40 years) colleagues continue to be at higher risk of poor well-being and burnout, two demographic groups noted to be particularly vulnerable in our previous J o u r n a l P r e -p r o o f surveys 4,5 and in the published literature 12, 13 . There is evidence that the pandemic has had an unequal impact on gender with female clinicians shouldering the greater burden of domestic responsibilities which may be exacerbating the pressure of growing professional demands. 14, 15 In Survey II, we previously highlighted concerns raised regarding career development, training and job security disproportionately impacting trainee and early-career oncologists. 5 Survey III broadens these concerns to that of a more widespread impending crisis in workforce retention. Alarmingly, one in four participants are considering changing their future career direction, of whom 38% are contemplating leaving the oncology profession altogether and 28% deliberating moving to a role within industry. This is on a background of perceived declining support from employers and national/global bodies.

Although our findings are compelling this study has its limitations. Survey III had a substantial Our study methodology involved optional online surveys which are associated with the risk of participant self-selection bias. However, on balance, this remains the optimal methodology for accessing a wider audience within the constraints and work pressures of oncology professionals working on the frontline during the COVID-19 pandemic. Our survey provides indicators of distress in participants but does not provide a definitive understanding of their mental health. As the WBI has been cross-validated with an increased risk of suicide, depression and anxiety there may be even graver psychological consequences associated with our study findings. 10, 17 Importantly, the impact of additional factors such as prolonged separation from loved ones should also not be underestimated.

Although the findings of the ESMO Resilience Taskforce Survey series are cause for concern, there are also reasons of optimism. Survey III highlights a significant increase in available wellbeing support services compared to pre-pandemic levels. Our data has allowed us to infer longitudinal trends but it does not provide us with an indication of future trends particularly given the dramatic changes in the global landscape that have ensued since Survey III was undertaken with many regions experiencing greater social freedoms. These are likely to be providing psychological relief and improvements in personal circumstances although the prevailing sense of professional uncertainty with the spectre of rising case numbers remains.

There is already some early evidence though of resilience in health services with oncology departments experiencing a return back to normal or higher clinical activity than before the pandemic.

The COVID-19 pandemic has also provided an opportunity for positive transformation. There are a number of adaptations to service delivery that should perhaps continue post-pandemic.

For instance, the beneficial impact on equitable access to clinical trials by facilitating greater access to telehealth encounters has been notable particularly for patients based in nonmetropolitan settings who often face greater travel time and financial toxicity to access novel therapies. 18 Remote site visits, greater use of electronic signatures and virtual meetings have also improved efficiency in clinical trial delivery which has been beneficial for all stakeholders.

For example, in Singapore, the pharmacy drug courier service has allowed a substantial number of patient prescriptions to be sent directly to their homes, improving overall quality of care. 19 21 The increased access to virtual oncology conferences and virtual mentorship programmes have also proven popular. 22 In the long-term, these initiatives may increase the ability of more staff to participate in professional development activities while balancing other commitments and mitigating financial cost.

A focus group study of American oncologists during the pandemic identified that many participants were strongly considering working part-time or taking early retirement. 23 Although this may seem concerning from a workforce planning viewpoint similar to our study, Proportions (percentage, %) are displayed as colours ranging from blue to red (with red denoting cause for concern i.e. increased job demands for (a) and decreased job resources in (b)), as shown in the key. Groups were compared using Chi-square test for trend (Survey I vs Survey II vs Survey III, where available). P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns, not significant; n/a, not applicable. See also Supplementary Table S3 . 

Summary of changes in professional duties since the COVID-19 outbreak reported by participants in Survey III (n = 1269).

Personal and work-related well-being resources and support services used by participants in Survey III (supplementary data to Figure 3 ).

Longitudinal Groups were compared using Chi-square analyses. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns, not significant; S I, Survey I; S II, Survey II; S III, Survey III; CI, confidence interval.

Self-reported levels of psychological resilience since the outbreak of the c Note that some participants have selected 2 or more specialties within their job role (to encompass differences in the scope of practice between countries/regions), and proportion of representation is summarised as such. Overall, participants have reported a mean of 15.1 ± 10.5 years of experience in the field of oncology.

J o u r n a l P r e -p r o o f 

COVID-19: impact on cancer workforce and delivery of care

Oncology nursing during a pandemic: critical reflections in the context of COVID-19

Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians

The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration

The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis

COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm

The impact of the COVID-19 pandemic on cancer care

Utility of a brief screening tool to identify physicians in distress

Ability of a 9-item Well-Being Index to identify distress and stratify quality of life in US workers

From burnout to resilience: an update for oncologists

Let's address burnout in oncologists and reimagine the way we work

COVID-19 pandemic and its gendered impact on Indian physicians

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey

The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk

Ability of the physician well-being index to identify residents in distress

American Society of Clinical Oncology road to recovery report: learning from the COVID-19 experience to improve clinical research and cancer care

Cancer versus COVID-19: a coordinated Disease Outbreak Response System (DORS) to combat COVID-19 at the National Cancer Centre Singapore

Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City

An academic-practice partnership during COVID-19 pandemic: Transitioning from a clinical to virtual fellowship

Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network

Impact of the COVID-19 pandemic on oncologist burnout, emotional well-being, and moral distress: considerations for the cancer organization's response for readiness, mitigation, and resilience

Australia) radiotherapy response to working through the first and second wave of COVID-19: Strategies and staffing

We would like to thank all participants for taking part, and national societies and organizations who helped distribute the survey. We would also like to thank Francesca Longo, Mariya Lemosle and Katharine Fumasoli from the ESMO Head Office for providing vital administrative support for the delivery of this study.